Provided by Tiger Trade Technology Pte. Ltd.

Boise Cascade

75.31
-0.6200-0.82%
Volume:340.75K
Turnover:25.75M
Market Cap:2.63B
PE:25.95
High:76.86
Open:76.28
Low:74.71
Close:75.93
52wk High:91.97
52wk Low:65.00
Shares:34.89M
Float Shares:34.34M
Volume Ratio:1.10
T/O Rate:0.99%
Dividend:0.88
Dividend Rate:1.17%
EPS(TTM):2.90
EPS(LYR):3.53
ROE:5.06%
ROA:2.86%
PB:1.30
PE(LYR):21.33

Loading ...

Boise Cascade Q1 EPS USD 0.5

THOMSON REUTERS
·
May 05

Stock Track | Boise Cascade Plummets 5.17% Intraday Ahead of Quarterly Earnings Report

Stock Track
·
May 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 01

Press Release: Boise Cascade Company Announces Quarterly Dividend of $0.22 Per Share

Dow Jones
·
May 01

The Plywood Smuggling Ring That Ensnared a Building-Products Giant -- WSJ

Dow Jones
·
Apr 29

Boise Cascade Pleads Guilty, Fined $6.38M for Role in Timber Trafficking Scheme

Dow Jones
·
Apr 28

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

GlobeNewswire
·
Apr 27

Earning Preview: Boise Cascade this quarter’s revenue is expected to decrease by 3.71%, and institutional views are mostly bullish

Earnings Agent
·
Apr 27

Analysts Offer Insights on Materials Companies: Reliance Steel (RS) and Boise Cascade (BCC)

TIPRANKS
·
Apr 24

Press Release: Boise Cascade Company First Quarter 2026 Earnings Webcast and Conference Call

Dow Jones
·
Apr 22

Boise Cascade Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 15

Boise Cascade price target lowered to $100 from $103 at Truist

TIPRANKS
·
Apr 15

Goldman Sachs Remains a Hold on Boise Cascade (BCC)

TIPRANKS
·
Apr 10

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

GlobeNewswire
·
Apr 10

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

GlobeNewswire
·
Apr 01

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

GlobeNewswire
·
Mar 26

Press Release: Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

Dow Jones
·
Mar 24

Boise Cascade Company publishes 2025 annual report

Reuters
·
Mar 21